<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05123508</url>
  </required_header>
  <id_info>
    <org_study_id>SCARCIP001</org_study_id>
    <nct_id>NCT05123508</nct_id>
  </id_info>
  <brief_title>Treatment of Breast Lift/Reduction Scars</brief_title>
  <official_title>Treatment of Surgical Scars Following Breast Lifts/Reductions</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sciton</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Sciton</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Laser and light treatment for surgical scars following breast lifts/reductions&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The purpose of the study is to demonstrate effectiveness of laser and light therapy for the&#xD;
      treatment of surgical scars following breast lifts/reductions.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Withdrawn</overall_status>
  <why_stopped>
    No subjects enrolled&#xD;
  </why_stopped>
  <start_date type="Actual">June 30, 2021</start_date>
  <completion_date type="Actual">October 21, 2021</completion_date>
  <primary_completion_date type="Actual">October 21, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Improvement in surgical scars</measure>
    <time_frame>3 months</time_frame>
    <description>Degree of improvement in scars using photographs assessed via modified Vancouver scar scale</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Overall improvement</measure>
    <time_frame>3 months</time_frame>
    <description>The Patient and Observer Scar Scale (POSAS)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Overall Improvement</measure>
    <time_frame>3 months</time_frame>
    <description>Global Aesthetic Improvement Scale (GAIS)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">0</enrollment>
  <condition>Scars</condition>
  <arm_group>
    <arm_group_label>Treatment Arm</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>2940nm laser and BBL treatment</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control Arm</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>One side of the treatment area will act as a control. No treatment on the control side.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>2940nm and BBL treatment</intervention_name>
    <description>2940nm and BBL treatment</description>
    <arm_group_label>Treatment Arm</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Non-treatment side (Control)</intervention_name>
    <description>No treatment</description>
    <arm_group_label>Control Arm</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Healthy female subjects between 25 to 60 years of age inclusive&#xD;
&#xD;
          2. Fitzpatrick skin type I-IV&#xD;
&#xD;
          3. Subjects with post-surgical breast lift/reduction scar&#xD;
&#xD;
          4. A maximum of 8-10 weeks since surgery&#xD;
&#xD;
          5. Healed surgery wound in the treatment area&#xD;
&#xD;
          6. Willing to have photographs taken of the treatment area&#xD;
&#xD;
          7. Can read, understand and sign informed consent form (English only)&#xD;
&#xD;
          8. Has indicated willingness to participate in the study by signing an informed consent&#xD;
             form&#xD;
&#xD;
          9. Agrees to adhere to the treatment and follow-up schedule and post treatment care&#xD;
             instructions&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Fitzpatrick skin type V-VI&#xD;
&#xD;
          2. Breast reconstruction with radiation treatment&#xD;
&#xD;
          3. Is pregnant and/or lactating&#xD;
&#xD;
          4. Has tattoos, dysplastic nevi in the treatment area&#xD;
&#xD;
          5. History or current photosensitivity&#xD;
&#xD;
          6. History or current use of medication with photosensitizing properties within past 6&#xD;
             months&#xD;
&#xD;
          7. History or current of chronic reoccurring skin disease or disorder affecting treatment&#xD;
             area&#xD;
&#xD;
          8. History or current cancer of any type&#xD;
&#xD;
          9. Has hormonal disorder&#xD;
&#xD;
         10. Has signs of actinic bronzing&#xD;
&#xD;
         11. Has open lacerations, and abrasions on the treatment area&#xD;
&#xD;
         12. History of keloid formation, or hypertrophic scar formation, or poor wound healing&#xD;
&#xD;
         13. History of bleeding disorder, or is currently taking anticoagulation medications&#xD;
&#xD;
         14. Has significant concurrent illnesses (controlled or uncontrolled), such as diabetes,&#xD;
             lupus, epilepsy, or cardiac disorders, which might be aggravated as a result of&#xD;
             treatment&#xD;
&#xD;
         15. Has participated in any clinical trial involving an investigational drug, device or&#xD;
             cosmetic product or procedure within the past 30 days&#xD;
&#xD;
         16. The investigator feels that for any reason the subject is not eligible to participate&#xD;
             in the study.&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>25 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Joel Cohen, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>AboutSkin Research, LLC</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jason Pozner, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Sanctuary Plastic Surgery</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>AboutSkin Research, LLC</name>
      <address>
        <city>Greenwood Village</city>
        <state>Colorado</state>
        <zip>80111</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sanctuary Plastic Surgery</name>
      <address>
        <city>Boca Raton</city>
        <state>Florida</state>
        <zip>33431</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>June 22, 2021</study_first_submitted>
  <study_first_submitted_qc>November 5, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">November 17, 2021</study_first_posted>
  <last_update_submitted>November 5, 2021</last_update_submitted>
  <last_update_submitted_qc>November 5, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 17, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Breast reduction scars</keyword>
  <keyword>Breast lift scars</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cicatrix</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

